Visibiome® Advanced GI Care
Natural health product licensed in Canada
- Licence holder
- Exegi Pharma, LLC
- NPN or DIN-HM
- 80061901
- Status
- Active licence
- Licence date
- 16 June 2015
- Revision date
- 19 October 2026
- Form
- Poudre
- Route of administration
- Orale
- Application type
- Non traditionnelle
If this product were sold in France
No point flagged by the rules we apply.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| Mélange de Probiotique Potency : 0 Streptococcus salivarius subsp. thermophilus SD5207 | 450 Milliards d'UFC | Not calculated |
| Mélange de Probiotique Potency : 0 Lactobacillus plantarum - Whole cell SD5209 | Not specified | Not calculated |
| Mélange de Probiotique Potency : 0 Lactobacillus delbrueckii subsp. blugaricus- Whole Cell 5210 | Not specified | Not calculated |
| Mélange de Probiotique Potency : 0 Bifidobacterium breve - Whole cell SD5206 | Not specified | Not calculated |
| Mélange de Probiotique Potency : 0 Lactobacillus paracasei - Whole cell SD5218 | Not specified | Not calculated |
| Mélange de Probiotique Potency : 0 Bifidobacterium animalis subsp. lactis- Whole Cell SD5220 | Not specified | Not calculated |
| Mélange de Probiotique Potency : 0 Bifidobacterium animalis subsp. lactis- Whole Cell SD5219 | Not specified | Not calculated |
| Mélange de Probiotique Potency : 0 Lactobacillus acidophilus - Whole cell SD5212 | Not specified | Not calculated |
Non-medicinal ingredients
Dioxyde de silicium, Phosphate de dipotassium, Chlorure de sodium, phosphate monobasique de potassium, Maltose, Trehalose, Saveur, Sucrose
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | Not specified | minimum: 0.5 packet ; maximum: 1 packet | 1 day |
| Adultes et enfants | minimum: 5 years | minimum: 0.5 packet ; maximum: 1 packet | 1 day |
| Adultes | Not specified | 2 sachet | 1 day |
| Adultes | Not specified | 4 sachet | 2 days |
Uses authorised in Canada
Text supplied in English because no French text is available.
Helps maintain the appropriate balance of beneficial bacteria in the bowel of pouchitis patients. Visbiome is used to reduce the risk of relapse in pouchitis patients. Visbiome, in conjunction with mesalamine, helps reduce the Ulcerative Colitis Disease Activity Index (UCDAI) by half within 6 weeks in some non-hospitalized patients with mild to moderately active ulcerative colitis. With daily use, provides ongoing relief of Irritable Bowel Syndrom (IBS) symptoms such as abdominal discomfort, gas, and bloating. For relief and management of IBS symptoms. Provides live microorganisms (bacteria) that form part of the natural healthy gut (or intestinal) flora. Probiotic that forms part of a natural healthy gut (intestinal) flora.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
No French warning text available in the imported data.
Warnings are available in English on the official record.
Source
Official Health Canada record, licence 80061901
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
List in the official revision dated (register: Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks).
Has the product changed? Photograph the packaging.